CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

Charles River partners with Magellan Stem Cells on cell therapy

PartnershipZelestrocelPositive
AI Analysis

Summary

Charles River has partnered with Australian biotech firm Magellan Stem Cells to advance development and clinical progress of Zelestrocel, a regenerative medicine candidate.

Importance:5/10
Sentiment:
0.30
partnershipcell therapyregenerative medicinecollaboration
Related Companies

Read the original article

Published by Pharmaceutical Technology on October 14, 2026 9:25 AM

Read Original